SIETES :: 92666 citas

Resultados de la búsqueda por USA REFINAR BÚSQUEDA

1.

Taylor P. Finch’s microbiota drug for C. diff gets FDA breakthrough status. PMLiVE 2019:11 de febrero. [Ref.ID 103019]

2.

Sánchez Caballero D. La OMS recomienda sacar el cannabis de la lista de sustancias más peligrosas y acerca la regulación terapéutica. eldiario.es 2019:8 de febrero. [Ref.ID 103018]

3.

Alexander M. Los calmantes opioides no funcionan para el dolor crónico. ¿Por qué los seguimos recetando?. eldiario.es 2019:27 de enero. [Ref.ID 103017]

4.

Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerdá M. Association of pharmaceutical industry marketing of opioid products with mortality from opioid-related overdoses. JAMA Network Open 2019;2:18 de enero. [Ref.ID 103009]

5.

Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy. A review. JAMA 2019;321:15 de enero. [Ref.ID 103008]

6.

Thielking M. Federal trial over fentanyl bribes gets underway. STAT Morning Rounds 2019:2. [Ref.ID 103007]

7.

Thielking M. PhRMA spent a record-breaking $27.5 million on lobbying in 2018. STAT Morning Rounds 2019:1. [Ref.ID 103004]

8.

Anónimo. AstraZeneca appoints controversial oncologist to head research and development unit.. DIA Daily 2019:13. [Ref.ID 102999]

9.

Bhupathiraju SN, Grodstein F, Stampfer MJ, Willett WC, Crandall CJ, Shifren JL, Manson JE. Vaginal estrogen use and chronic disease risk in the Nurses' Health Study. Menopause 2018:17 de diciembre. [Ref.ID 102910]

10.

Florko N. Powerful Democrat wants Pfizer to explain price hikes for Lyrica, its nerve pain drug. STAT Daily Recap 2018:5. [Ref.ID 102907]

11.

Ray WA, Stein CM, Murray KT, Fuchs DC, Patrick SW, Daugherty J, Hall K, Cooper WO. Association of antipsychotic treatment with risk of unexpected death among children and youths. JAMA Psychiatry 2018:12 de diciembre. [Ref.ID 102895]

12.

Healy D. The Goetzsche affair. Dr. David Healy (blog) 2018:5 de noviembre. [Ref.ID 102892]

13.

Goodwin JS, Kuo Y-F, Brown D, Juurlink D, Raji M. Association of chronic opioid use with presidential voting patterns in US counties in 2016. JAMA Network Open 2018;1:22 de junio. [Ref.ID 102891]

14.

Cooney E. Novartis unit teams up with medical marijuana producer, marking milestone for pharma. STAT Daily Recap 2018:18 de diciembre. [Ref.ID 102888]

15.

Wallach JD, Eqilman AC, Dhruva SS, McCarthy ME, Miller JE, Woloshin S, Schwartz LM, Ross JS. Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis. BMJ 2018;361:24 de mayo. [Ref.ID 102886]

16.

Moore TJ, Mattison DR. Assessment of patterns of potentially unsafe use of zolpidem. JAMA Intern Med 2018;178:septiembre. [Ref.ID 102884]

17.

Dayoub EJ, Seigerman M, Tuteja S, Kobayashi T, Kolansky DM, Giri J, Groeneveld PW. Trends in platelet adenosine diphosphate P2Y12 receptor inhibitor use and adherence among antiplatelet-naive patients after percutaneous coronary intervention, 2008-2016. JAMA Intern Med 2018;178:julio. [Ref.ID 102882]

18.

Layton TJ, Barnett ML, Hicks TR, Jena AB. Attention deficit-hyperactivity disorder and month of school enrollment. N Engl J Med 2018;379:29 de noviembre. [Ref.ID 102876]

19.

Anónimo. Johnson & Johnson begins settling consumer lawsuits over marketing of defective artificial hips. DIA Daily 2018:1. [Ref.ID 102874]

20.

Anónimo. Generic drug “cartel” probe now examining at least 16 companies.. DIA Daily 2018:1. [Ref.ID 102873]